From a molecular medicine standpoint, Relafen 750 (Naproxen ) presents a fascinating case study in therapeutic action. Its mechanism of effect primarily involves the inhibition of cyclooxygenase ( COX enzymes ) enzymes, particularly COX-II , leading to a decrease in the synthesis of inflammatory